Agilent Technologies (NYSE:A) Upgraded by Wall Street Zen to “Buy” Rating

Agilent Technologies (NYSE:AGet Free Report) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.

A number of other analysts have also weighed in on A. Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and decreased their target price for the stock from $150.00 to $145.00 in a report on Thursday. Wells Fargo & Company decreased their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday. Barclays lifted their target price on shares of Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a research report on Thursday. UBS Group dropped their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Finally, Morgan Stanley dropped their target price on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Two investment analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, Agilent Technologies presently has a consensus rating of “Buy” and an average price target of $162.79.

View Our Latest Stock Analysis on A

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $135.38 on Friday. The firm’s 50 day simple moving average is $115.93 and its 200 day simple moving average is $128.76. The company has a current ratio of 2.10, a quick ratio of 1.59 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $38.26 billion, a PE ratio of 27.19, a price-to-earnings-growth ratio of 2.84 and a beta of 1.22. Agilent Technologies has a 1-year low of $108.35 and a 1-year high of $160.27.

Agilent Technologies (NYSE:AGet Free Report) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. Agilent Technologies’s revenue was up 10.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts expect that Agilent Technologies will post 5.97 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilent Technologies

A number of hedge funds have recently made changes to their positions in A. Brighton Jones LLC lifted its holdings in shares of Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after acquiring an additional 270 shares during the last quarter. Jones Financial Companies Lllp lifted its holdings in shares of Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after acquiring an additional 769 shares during the last quarter. Geneos Wealth Management Inc. lifted its holdings in shares of Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after acquiring an additional 212 shares during the last quarter. Acadian Asset Management LLC lifted its holdings in shares of Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after acquiring an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in shares of Agilent Technologies in the 2nd quarter worth approximately $273,000.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

Agilent Technologies Company Profile

(Get Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Read More

Analyst Recommendations for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.